Akèy › Sarkom tisi mou › Missouri › St. Louis
Etid klinik pou Sarkom tisi mou nan St. Louis, MO
14 etid pou Sarkom tisi mou ap chèche patisipan nan sit nan ak bò kote St. Louis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- ak 4 plis
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Ap rekriteFaz 1/2
- Washington University School of Medicine in St. Louis, St Louis
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
Ap rekriteFaz 1
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
Ap rekriteFaz 1/2
- Washington University in St. Louis, St Louis
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
Ap rekriteEtid obsèvasyon
- Washington University School of Medicine, St Louis
IDOV-Immune for Advanced Solid Tumors
Ap rekriteFaz 1
- Washington University School of Medicine, St Louis
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
Ap rekriteFaz 1/2
- Washington University Medical Center, St Louis
Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
Ap rekriteFaz 2
- Washington University in St. Louis, St Louis
Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors
Ap rekriteFaz 1
- Zai Lab Site 02005, St Louis
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Ap rekriteFaz 1/2
- Saint Louis University, St Louis
Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Ap rekriteFaz 1
- Washington University School of Medicine, St Louis
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Ap rekriteFaz 1/2
- Washington University Infusion Center Pharmacy, St Louis
Propranolol for the Treatment of Kaposi Sarcoma in Adults
Ap rekriteFaz 2
- Washington University School of Medicine, St Louis
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Washington University School of Medicine, St Louis
Etid Sarkom tisi mou nan lòt vil
- Houston, TX32 etid
- New York City, NY19 etid
- Boston, MA18 etid
- Los Angeles, CA13 etid
- Columbus, OH13 etid
- Washington, DC12 etid
- Memphis, TN11 etid
- Philadelphia, PA10 etid
- Rochester, MN9 etid
- Nashville, TN9 etid
- Aurora, CO9 etid
- Queens, NY9 etid
Lòt etid nan St. Louis
- Kansè Poumon ki pa ti selil73 etid
- Kansè nan tete64 etid
- Kansè Metastatik54 etid
- Kansè kolorektal50 etid
- Kansè pwostat46 etid
- Kansè (tout kalite)46 etid
- Kansè poumon39 etid
- Kansè ovè38 etid
- Kansè pankreyas33 etid
- Kansè Endomèt29 etid
- Karsinòm selil skuamèz tèt ak kou28 etid
- Ensifizyans kadyak26 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.